News
Nightingale – a Finnish company on a mission to solve the global chronic disease crisis
6.8.2019
According to the World Health Organization, at least 80 % of all heart disease, stroke ...
Pharmaceutical injuries insurance
27.6.2019
In Finland there is a voluntary compensation system to protect medicine users: pharmaceutical injuries insurance. ...
HIMSS & Health 2.0 European Conference
25.6.2019
HIMSS & Health 2.0 European conference took place on 11-13.6.2019 in Helsinki. 3 000 professionals ...Suomalainen tutkimuskenttä muuttuu – useita lakiuudistuksia tulossa
17.6.2019
Miten suomalainen tutkimuskenttä muuttuu lakiuudistusten myötä? Sirpa Soinin (varatuomari, THL Biopankin johtaja) erikoisalaa ovat kansanterveyteen, ...
Medaffcon on Twitter
06.08.2019 5:59
How could chronic diseases be prevented? Medaffcon met with Nightingale Health, a #Finnish company on a mission to solve the global #chronicDisease crisis. Read our newest Future Care Finland article. #biotech https://t.co/2wYMlDv3UL
How could chronic diseases be prevented? Medaffcon met with Nightingale Health, a #Finnish company on a mission to solve the global #chronicDisease crisis. Read our newest Future Care Finland article. #biotech https://t.co/2wYMlDv3UL
01.08.2019 5:42
How does the #Finnish #pharmaceutical injuries insurance work? Tiina Hellgrén, LLM, CEO of the Finnish Mutual Insurance Company for Pharmaceutical Injury Indemnities, explains this in the recently published Future Care Finland article https://t.co/gzqLKEtBPt
How does the #Finnish #pharmaceutical injuries insurance work? Tiina Hellgrén, LLM, CEO of the Finnish Mutual Insurance Company for Pharmaceutical Injury Indemnities, explains this in the recently published Future Care Finland article https://t.co/gzqLKEtBPt
04.07.2019 7:17
A new real-world #study published: This real-world study demonstrates that adult #asthma represents a significant #disease burden in #Finland, with an increased burden in patients with severe and/or eosinophilic disease. Read the whole study https://t.co/sJCtE9iB4p
A new real-world #study published: This real-world study demonstrates that adult #asthma represents a significant #disease burden in #Finland, with an increased burden in patients with severe and/or eosinophilic disease. Read the whole study https://t.co/sJCtE9iB4p
